Welcome to our dedicated page for Health Catalyst news (Ticker: HCAT), a resource for investors and traders seeking the latest updates and insights on Health Catalyst stock.
Health Catalyst, Inc. (HCAT) delivers data analytics and technology solutions that empower healthcare organizations to improve clinical outcomes. This page serves as a comprehensive resource for investors and industry professionals tracking the company’s strategic developments.
Key updates include earnings reports, product launches, leadership changes, and partnership announcements. Users will find verified press releases and curated news articles covering HCAT’s technology innovations, client expansions, and financial performance.
Regular updates feature developments in healthcare data warehousing, cloud analytics platforms, and professional service offerings. Content highlights operational milestones, regulatory compliance achievements, and market expansion efforts within the healthcare IT sector.
Bookmark this page to monitor Health Catalyst’s progress in enabling data-driven care improvements through its adaptive data architecture and analytics expertise. Check back for objective reporting on HCAT’s role in advancing healthcare interoperability and operational efficiency.
Health Catalyst (Nasdaq: HCAT) has scheduled its first quarter 2025 operating results announcement for Wednesday, May 7, 2025, after market close. The healthcare data and analytics technology provider will host a conference call at 5:00 pm ET on the same day to discuss the results.
U.S. participants can join the call by dialing 800-343-5172, while international participants should dial 203-518-9856, using conference ID 'HCATQ125'. A live audio webcast will be accessible at ir.healthcatalyst.com, with a replay available for approximately 90 days after the call.
Health Catalyst (HCAT) has launched Health Catalyst Ignite Spark™, a specialized data and analytics solution targeting community health systems, regional hospitals, and multi-site practices. The platform is designed to help smaller healthcare organizations facing challenges of shrinking margins and resource constraints.
The solution offers key features including:
- Data integration and normalization from multiple sources
- Centralized governance
- Self-service access to actionable insights
- AI-driven decision-making capabilities
- Reduced IT burden and costs
Ignite Spark aims to break down cost, access, and expertise barriers for regional hospital networks, primary care networks, urgent care centers, and specialty practices, enabling data-driven improvements in clinical operations, revenue performance, and cost control.
Health Catalyst (HCAT) has announced a stock repurchase of approximately $5 million, executed between March 3-10, 2025. The company retired approximately 1.1 million shares of common stock as part of its existing share repurchase program, which was authorized in August 2022 with a total capacity of $40 million.
CEO Dan Burton stated that the repurchase reflects the company's confidence in its future, citing that current market prices don't reflect their long-term value. The company anticipates continued achievement of operating leverage and revenue growth reacceleration, emphasizing their commitment to creating sustainable value for shareholders, clients, and team members.
Health Catalyst (Nasdaq: HCAT) has entered into a multi-year agreement with Signature Healthcare, an integrated healthcare delivery system in Southeastern Massachusetts. The partnership centers on implementing Health Catalyst Ignite™, a modern data and analytics ecosystem that integrates clinical and claims data while enhancing care coordination.
The solution will enable Signature Healthcare to leverage data insights for supporting quality patient outcomes and optimizing operational performance. The platform integrates best-in-class cross-industry technologies with healthcare-specific data models and self-service tools in a scalable environment.
Robert Haffey, Signature Healthcare's President and CEO, emphasized the alignment between Health Catalyst's solutions and their leadership team's governance objectives. The partnership aims to enhance patient health and wellness while supporting operational excellence, with Health Catalyst providing population health expertise to maximize Ignite's capabilities.
Health Catalyst (HCAT) reported strong financial results for Q4 and full-year 2024, achieving total revenue of $307 million and Adjusted EBITDA of $26 million for 2024. The Technology segment showed notable performance with revenue of $195 million for full-year 2024 and $52 million for Q4 2024, representing 10% year-over-year growth.
The company provided guidance for 2025, projecting total revenue of approximately $335 million, Technology revenue of $220 million, and raised their Adjusted EBITDA target by $2 million to $41 million. For Q1 2025, they expect revenue of approximately $79 million and Adjusted EBITDA of $4 million.
The company announced governance updates, including the appointment of Dr. Jill Hoggard Green to the Board of Directors and the promotion of Dr. Daniel Samarov to Chief AI Officer.
Health Catalyst (HCAT), a leading healthcare data and analytics technology provider, has announced its participation in the Raymond James & Associates' 46th Annual Institutional Investors Conference in Orlando, FL. The company's executive team, including CEO Dan Burton, CFO Jason Alger, COO Dan LeSueur, and VP of Investor Relations Jack Knight, will conduct a fireside chat presentation on Tuesday, March 4, 2025, at 1:40 p.m. ET.
Interested parties can access the webcast through Health Catalyst's investor relations website at https://ir.healthcatalyst.com.
Health Catalyst (HCAT) has announced it will release its fourth quarter and full year 2024 operating results on Wednesday, February 26, 2025, after market close. The company will host a conference call at 5:00 pm ET on the same day to review the results. U.S. participants can join by dialing 800-343-5172, while international participants can dial 203-518-9856, using conference ID 'HCATQ424'. A live audio webcast will be available at ir.healthcatalyst.com, with a replay accessible for approximately 90 days after the call.
Health Catalyst (Nasdaq: HCAT) has announced its participation in an upcoming investor conference. The company's leadership team, including Chief Executive Officer Dan Burton, Chief Financial Officer Jason Alger, and Chief Operating Officer Dan LeSueur, will attend the BTIG at Snowbird: MedTech, Digital Health, Life Science & Diagnostic Tools Conference. The event is scheduled to take place on February 11, 2025, in Snowbird, UT. Health Catalyst is known for providing data and analytics technology and services to healthcare organizations.
Modern Health has appointed Adam Brown as Chief Financial Officer, strengthening its executive team. Brown brings over fifteen years of healthcare finance experience, most recently serving as Senior VP of Financial Planning & Analysis and Investor Relations at Health Catalyst (NASDAQ: HCAT).
At Health Catalyst, Brown was instrumental in scaling the company from a venture-backed startup to a public company with over $300M in revenue and 1,400+ team members. He managed multiple funding rounds, including the company's IPO, and oversaw six acquisitions. His previous experience includes positions at GTCR's private equity healthcare practice and Bank of America Merrill Lynch's healthcare investment banking group.
The appointment follows Modern Health's recent developments, including a RAND Europe peer-reviewed study on global mental health support engagement and the acquisition of Anvil Health's AI technology.
Health Catalyst (Nasdaq: HCAT) has announced a multi-year partnership with OrthoNebraska, a leading orthopedic care provider based in Omaha, Nebraska. The partnership will leverage Health Catalyst's Ignite™ platform, a comprehensive data and analytics ecosystem designed to enhance patient outcomes, operational efficiency, and personalized patient experiences.
Ignite integrates clinical, financial, and patient experience data into a unified healthcare model, providing OrthoNebraska with a single access point for key performance indicators. This integration will enable OrthoNebraska to make more informed, data-driven decisions through self-service tools and enhanced analytics transparency.
OrthoNebraska's CEO, Levi Scheppers, emphasized that the partnership will simplify and personalize musculoskeletal healthcare by providing near real-time information to specialized teams. Health Catalyst will also offer ongoing operational support, including data source configuration, governance, and security administration.
Health Catalyst's CEO, Dan Burton, highlighted the importance of integrated data for improving patient outcomes and operational performance, noting that the Ignite platform is a scalable, long-term solution tailored for healthcare.
